|
|
|
| Influence of vitamin D assisted reduced glutathione on hepatic lipidosis and intestinal flora in patients with type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease |
| Reyihannisha·Yakeya Zulipiya·Nuermaimaiti Yilimire·Nuermaimaiti |
Department of Endocrinology, the First People’s Hospital of Kashgar, Xinjiang Uygur Autonomous Region, Kashgar 844000, China
|
|
|
|
Abstract Objective To investigate the effect of vitamin D assisted reduced glutathione in the treatment of type 2 diabetes mellitus (T2DM) complicated with non-alcoholic fatty liver disease (NAFLD) and its influence on hepatic lipidosis and intestinal flora. Methods A total of 168 patients with T2DM complicated with NAFLD admitted to the Department of Endocrinology of the First People’s Hospital of Kashgar, Xinjiang Uygur Autonomous Region from July 2019 to October 2020 were selected as the study objects. According to the random number table method, they were divided into control group and observation group, with 84 cases in each group. The control group received conventional treatment and reduced glutathione, and the observation group received vitamin D assisted therapy on the basis of the control group. The treatment course of both groups was three months. The efficacy of NAFLD was compared between the two groups, and the liver function, liver fat deposition, intestinal flora, and blood glucose indexes before and after treatment were compared between the two groups. Results There were two cases in the control group and four cases in the observation group during the treatment. The efficacy of NAFLD in the observation group was better than that in the control group (P＜0.05). After treatment, glutamic pyruvic transaminase (GPT), glutamic oxaloacetic aminotransferase (GOT), γ-glutamyltransferase (GGT), controlled attenuation parameter (CAP), liver stiffness measurement (LSM), liver fat content, and levels of Escherichia coli, fasting blood glucose (FPG), 2 h postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c) of two groups were lower than those before treatment, while levels of Bifidobacterium and Lactobacillus in two groups were higher than those before treatment (P＜0.05). After treatment, GPT, GOT, GGT, CAP, LSM, liver fat content, and levels of Escherichia coli, FPG, 2hPG, HbA1c in observation group were lower than those in control group, while levels of Bifidobacterium and Lactobacillus were higher than those in control group (P＜0.05). Conclusion Vitamin D-assisted reduced glutathione has a good effect in the treatment of T2DM patients with NAFLD, which can improve clinical effect, improve liver function, reduce liver lipidosis, and regulate intestinal flora.
|
|
|
|
|
|
[1] 肖露，胡弦，蔡颖珂，等.腺苷蛋氨酸联合还原型谷胱甘肽治疗药物性肝损伤患者疗效研究[J].实用肝脏病杂志，2022，25（1）：66-69.
[2] 黄金华，鲁翠红.健康体检人群血清25-羟基维生素D水平与非酒精性脂肪肝的关系[J].海南医学，2019，30（2）：179-182.
[3] 付丽坤，崔红梅，卢坤玲，等.血清25（OH）维生素D与非酒精性脂肪肝肝脏脂肪含量的相关性[J].南方医科大学学报，2019，39（9）：1118-1121.
[4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2020年版）[J].中华糖尿病杂志，2021，13（4）：315-409.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝诊疗指南（2010年修订版）[J].中华肝脏病杂志，2010，18（3）：163-166.
[6] 林淑珍，刘志华，齐青松，等.熊去氧胆酸胶囊联合甘草酸二铵肠溶胶囊治疗非酒精性脂肪肝的疗效及其对ALT、AST、GGT水平的影响[J].检验医学与临床，2021， 18（3）：395-398.
[7] Mundi MS，Velapati S，Patel J，et al. Evolution of NAFLD and Its Management [J]. Nutr Clin Pract，2020，35（1）：72- 84.
[8] 潘晓洁，斯徐伟，尤巧英，等.2型糖尿病合并NAFLD患者FA水平及代谢指标的相关性研究[J].医学研究杂志，2021，50（5）：80-83.
[9] 杨馥宇，苏杰，王玲，等.还原型谷胱甘肽调控Nrf2/iNOS信号对DR大鼠视网膜的保护机制[J].转化医学杂志，2022，11（1）：36-41.
[10] 段昕妤，吴凯，朱超慧，等.还原型谷胱甘肽联合多烯磷脂酰胆碱对急性药物性肝损伤患者肝功能、肝纤维化指标及血清炎性因子的影响[J].现代生物医学进展，2021，21（14）：2679-2682.
[11] 王永斌，陆奎英，苏勇，等.非酒精性脂肪肝患者肝功能、氧化应激水平变化及临床意义[J].检验医学，2020， 35（9）：903-907.
[12] 丁光伟，段淑芬，高春耕，等.更昔洛韦联合还原型谷胱甘肽对巨细胞病毒性肝炎患者肝功能及Th1/Th2平衡的影响[J].中西医结合肝病杂志，2021，31（5）：424- 427.
[13] 杨婧，赵耀伟，高红，等.CCN蛋白对肥胖症和非酒精性脂肪肝防治机制的研究进展[J].中国病理生理杂志，2020，36（10）：1902-1907.
[14] 曲玉蕾，王迎春，万金鑫.非酒精性脂肪肝与血清维生素D及骨密度的关系[J].临床肝胆病杂志，2019，35（9）：2021-2025.
[15] 郝瑞瑞，王欢，罗佳，等.老年非酒精性脂肪肝与维生素D水平的关系研究[J].临床和实验医学杂志，2019，18（23）：2473-2476.
[16] 张文龙，叶鹏，魏东.2型糖尿病合并非酒精性脂肪肝患者中血镁与胰岛素抵抗的相关性[J].海南医学，2021， 32（12）：1520-1523.
[17] 吕齐欢，周剑，康冬梅.老年2型糖尿病患者血清维生素D与T细胞亚群水平及胰岛素抵抗的关系[J].安徽医学，2020，41（6）：661-664.
[18] 张黎雯，任明星，薛国昌，等.肠道菌群失调对肥胖儿童非酒精性脂肪肝发生的影响[J].肝脏，2020，25（7）：755-758.
[19] 邱邦东，臧月，王生，等.鳖甲煎丸改善肠道菌群失调治疗大鼠非酒精性脂肪肝的机制探讨[J].中国实验方剂学杂志，2017，23（4）：145-151.
[20] 汪玲娟，张建萍，陈慕恒.益生菌对非酒精性脂肪肝患儿肝功能糖脂代谢及肠道菌群的影响[J].中国学校卫生，2019，40（10）：1545-1548.
[21] 傲雪，周翔海，张秀英，等.非酒精性脂肪肝的危险因素探讨[J].中国临床医生杂志，2021，49（2）：165-169.
[22] 盛佳智，弓腊梅.运动对非酒精性脂肪肝患者肠道菌群的影响研究进展[J].生理科学进展，2020，51（1）：25-28.
[23] 易艳容，曾亚，何佳，等.非酒精性脂肪肝患者肠道菌群变化及双歧杆菌三联活菌胶囊对肠道菌群、肝功能、血脂及胰岛素抵抗的影响[J].中国肝脏病杂志（电子版），2016，8（3）：87-92.
[24] 汪婷，章秋，刘安诺，等.维生素D口服辅助治疗2型糖尿病伴轻度认知功能障碍临床观察[J].山东医药，2017， 57（27）：73-75.
[25] 姜鹤，刘铁群.维生素D辅助治疗老年2型糖尿病合并肥胖患者的临床效果[J].中国老年学杂志，2018，38（23）：5684-5686. |
|
|
|
